Skip to main content
SpringerLink
Log in

Desmoid tumors

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Because of the wide variety of anatomic locations and patient factors, there is no one treatment that is appropriate for all desmoid tumors. The type of treatment depends on tumor characteristics and location, as well as patient characteristics and preferences. Desmoid tumors can be persistent and frustrating to manage because no one treatment modality offers a high likelihood of remission. Multiple modalities may be necessary in some patients. Although mortality is rare and is usually due to local complications, significant disability or morbidity can result from desmoid tumors, their treatment, and complications arising from treatment. The entire clinical picture and the patient’s preferences must be taken into account when deciding on an appropriate treatment plan. Patients with desmoid tumors are optimally managed in a multidisciplinary setting with close collaboration between surgeon, pathologist, diagnostic radiologist, radiation oncologist, and medical oncologist. When possible, surgical resection with negative margins is the preferred modality. When surgical resection with negative margins may prove disabling, surgery can be followed by postoperative radiation, although the role and efficacy of this are controversial. In locations where surgical extirpation is difficult or unfeasible, primary radiation, hormonal therapy, or chemotherapy should be considered. Familiar adenosis polyposis (FAP)-associated mesenteric lesions, sporadic tumors present without change for months or years, or tumors present in areas where progression will not present significant additional morbidity are candidates for observation only.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Anthony T, Rodriguez-Bigas MA, Weber TK, Petrelli NJ: Desmoid tumors. J Am Coll Surg 1996, 182:369–377.

    PubMed  CAS  Google Scholar 

  2. Icard P, Le Rochais JP, Galateau F, Evrard C: Desmoid fibromatosis of the shoulder and of the upper chest wall following a clavicular fracture. Eur J Cardio Thorac Surg 1999, 15:723–725.

    Article  CAS  Google Scholar 

  3. De Cian F, Delay E, Rudigoz RC, et al.: Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management. Gynecol Oncol 1999, 75:145–148.

    Article  PubMed  Google Scholar 

  4. Kaplan DB, Levine EA: Desmoid tumor arising in a laparoscopic trocar site. Am Surg 1998, 64:388–390.

    PubMed  CAS  Google Scholar 

  5. Clark SK, Phillips RK: Desmoids in familial adenomatous polyposis. Br J Surg 1996, 83:1494–1504. A review of 166 desmoids in 88 patients is presented. The authors find that while abdominal wall desmoids caused no death and little morbidity, intra-abdominal desmoids can cause serious complications, and treatment is often unsuccessful.

    Article  PubMed  CAS  Google Scholar 

  6. Heiskanen I, Jarvinen HJ: Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996, 11:157–162.

    Article  PubMed  CAS  Google Scholar 

  7. Vandevenne JE, De Schepper AM, De Beuckeleer L, et al.: New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. European Radiology 1997, 7:1013–1019.

    Article  PubMed  CAS  Google Scholar 

  8. Maurer F, Horst F, Pfannenberg C, Wehrmann M: Multifocal extra-abdominal desmoid tumor diagnostic and therapeutic problems. Arch Orthop Trauma Surg 1996, 115:359–362.

    Article  PubMed  CAS  Google Scholar 

  9. Sabate JM, Parellada JA, Franquet T, et al.: Metachronous multicentric aggressive fibromatosis with mediastinal involvement. Eur Radiol 1996, 6:207–209.

    Article  PubMed  CAS  Google Scholar 

  10. Gaposchkin CG, Bilsky MH, Ginsberg R, Brennan MF: Function-sparing surgery for desmoid tumors and other low-grade fibrosarcomas involving the brachial plexus. Neurosurgery 1998, 42:1297–301.

    Article  PubMed  CAS  Google Scholar 

  11. Merchant NB, Lewis JJ, Woodruff JM, et al.: Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 1999, 86:2045–2052. One hundred and five patients with desmoid tumor are reviewed. The authors note that in their series, age, gender, depth of tumor, size of tumor or tumor site, and positive margin are not predictions of local recurrence.

    Article  PubMed  CAS  Google Scholar 

  12. Spear MA, Jennings LC, Mankin HJ, et al.: Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998, 40:637–645. This study reviewed 107 fibromatosis cases. The authors recommend radiation following surgery with positive margins, or for tumors in which resection would result in significant functional or cosmetic defects.

    Article  PubMed  CAS  Google Scholar 

  13. Spiegel DA, Dormans JP, Meyer JS, et al.: Aggressive fibromatosis from infancy to adolescence. J Pediatr Orthop 1999, 19:776–784.

    Article  PubMed  CAS  Google Scholar 

  14. Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors. Cancer 1993, 72:3244–3247.

    Article  PubMed  CAS  Google Scholar 

  15. Fernberg JO, Brosjo O, Larsson O, et al.: Interferoninduced remission in aggressive fibromatosis of the lower extremity. Acta Oncol 1999, 38:971–972.

    Article  PubMed  CAS  Google Scholar 

  16. Leithner A, Schnack B, Katterschafka T, et al.: Treatment of extra-abdominal desmoid tumors with interferonalpha with or without tretinoin. J Surg Oncol 2000, 73:21–25.

    Article  PubMed  CAS  Google Scholar 

  17. Weiss AJ, Horowitz S, Lackman RD, Lackman RD: Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol 1999, 22:193–195.

    Article  PubMed  CAS  Google Scholar 

  18. Skapek SX, Hawk BJ, Hoffer FA, et al.: Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 1998, 16:3021–3027.

    PubMed  CAS  Google Scholar 

  19. Izes JK, Zinman LN, Larsen CR: Regression of large pelvic desmoid tumor by tamoxifen and sulindac. Urology 1996, 47:756–759.

    Article  PubMed  CAS  Google Scholar 

  20. Benson JR, Mokbel K, Baum M: Management of desmoid tumours including a case report of toremifene. Ann Oncol 1994, 5:173–177.

    PubMed  CAS  Google Scholar 

  21. Suit H, Spiro I: Radiation as a therapeutic modality in sarcomas of the soft tissue. Hematol Oncol Clin North Am 1995, 9:733–746.

    PubMed  CAS  Google Scholar 

  22. Kamath SS, Parsons JT, Marcus RB, et al.: Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 1996, 36:325–328.

    Article  PubMed  CAS  Google Scholar 

  23. Pritchard DJ, Nascimento AG, Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg 1996, 78:848–854. Fifty patients treated for desmoid tumor were reviewed and treated with surgery, radiation, both surgery and radiation, or observation. No patients died of disease.

    PubMed  CAS  Google Scholar 

  24. Ballo MT, Zagars GK, Pollack A: Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 1998, 42:1007–1014. The outcome of 189 patients treated for desmoid tumor who received radiation is retrospectively reviewed. The authors conclude that radiation is an effective modality and should be recommended following positive-margin surgery, or for unresectable tumors.

    Article  PubMed  CAS  Google Scholar 

  25. Goy BW, Lee SP, Fu YS, et al.: Treatment results of unresected or partially resected desmoid tumors. Am J Clin Oncol 1998, 21:584–590.

    Article  PubMed  CAS  Google Scholar 

  26. Shin KH, Shin SJ, Lee DH, et al.: The role of radiotherapy in the treatment of aggressive fibromatosis. Yonsei Med J 1999, 40:439–443.

    PubMed  CAS  Google Scholar 

  27. Faulkner LB, Hajdu SI, Kher U, et al.: Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol 1995, 13:2813–2818.

    PubMed  CAS  Google Scholar 

  28. Mahoney J, Bell RH, Hudson AR, et al.: Aggressive fibrous tissue lesions in the upper extremity: treatment and results. J Hand Surg Am 1994, 19:686–693.

    PubMed  CAS  Google Scholar 

  29. Ballo MT, Zagars GK, Pollack A, et al.: Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999, 17:158–167.

    PubMed  CAS  Google Scholar 

  30. Higaki S, Tateishi A, Ohno T, et al.: Surgical treatment of extra-abdominal desmoid tumours (aggressive fibromatoses). Int Orthop 1995, 19:383–389.

    Article  PubMed  CAS  Google Scholar 

  31. Lev-Chelouche D, Abu-Abeid S, Nakache R, et al.: Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Surgery 1999, 126:963–967.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Orthopaedic Surgery, University of Michigan, 1500 E Medical Center Drive, 7304 CCGC, 48109-0946, Ann Arbor, MI, USA

    J. Sybil Biermann MD

Authors
  1. J. Sybil Biermann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biermann, J.S. Desmoid tumors. Curr. Treat. Options in Oncol. 1, 262–266 (2000). https://doi.org/10.1007/s11864-000-0038-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-000-0038-5

Keywords

Search

Navigation